In accordance with US securities regulations, Novartis files reports with the Securities and Exchange Commission. View all of the Novartis filings through EDGAR, the Electronic Data Gathering, Analysis and Retrieval system, on the SEC website.
SEC filings (EDGAR)
Investors International:Call +41 61 324 79 44
Investors North America:Call +1 212 830 24 48
For information relating to the registration of your shares, including name or address changes, please contact us by e‑mail or telephone:
Share Registry:Call +41 61 324 72 04
This site is intended for a global audience.